CCRN · Cardiovascular · 9 min read
Dysrhythmias, Conduction Defects and Cardioversion
- Distinguish life-threatening bradydysrhythmias, atrioventricular blocks, and intraventricular conduction defects while prioritizing emergency interventions such as transcutaneous pacing and targeted pharmacotherapy.
- Differentiate supraventricular and ventricular tachyarrhythmias, identifying appropriate protocols for vagal maneuvers, antiarrhythmic administration, and electrical cardioversion or defibrillation.
- Apply safe critical care nursing practices for electrical cardioversion, procedural sedation, and antiarrhythmic therapies guided by hemodynamic monitoring and the AACN Synergy Model.
Symptomatic Bradycardia and Emergency Pacing
In the critical care unit, symptomatic bradycardia is recognized when an abnormally low heart rate directly impairs systemic perfusion. Rather than relying on a numerical rate alone, the bedside nurse evaluates the patient for clear signs of inadequate organ perfusion. These clinical manifestations include systemic hypotension, acute alterations in mental status, ischemic chest pain, and the sudden emergence of acute pulmonary edema. Recognizing these signs requires rapid synthesis of bedside data to prevent imminent cardiovascular collapse.
When an adult presents with symptomatic bradycardia and poor perfusion, initial pharmacologic management under an ACLS protocol or provider order begins with atropine 1 mg administered by rapid intravenous push. This dose may be repeated every 3 to 5 minutes as needed, reaching a maximum total dose of 3 mg. However, critical care nurses must anticipate clinical limitations: atropine is generally ineffective when conduction failure originates within the sub-nodal His-Purkinje system, which characterizes high-grade atrioventricular blocks like Mobitz Type II or third-degree atrioventricular block accompanied by a wide QRS complex.
For patients with high-grade conduction blocks or bradycardia refractory to atropine, transcutaneous pacing serves as the primary emergency non-pharmacologic intervention. Under an ACLS protocol or provider order, transcutaneous pacing can be instituted immediately, alongside continuous infusions of dopamine or epinephrine. These vasoactive infusions are carefully titrated to ordered hemodynamic goals while the nurse frequently reassesses patient perfusion. Continuous intra-arterial blood pressure monitoring, when available, provides real-time beat-to-beat hemodynamic assessment during infusion titration and concurrent dysrhythmia management.
Verifying effective transcutaneous pacing requires confirming both electrical and mechanical capture. Electrical capture is observed on the cardiac monitor by a distinct pacing spike followed immediately by a wide QRS complex and a broad T wave. Mechanical capture must be verified independently; the nurse palpates a central pulse, preferably the femoral pulse, ensuring that each pulsed beat corresponds directly to an electrically paced QRS complex. An indwelling arterial pressure line waveform provides valuable additional confirmation of true mechanical ventricular output.
Common mistakes
- Relying on atropine for infranodal conduction disturbances: Mobitz Type II block and wide-QRS complete AV block often respond poorly to atropine; prepare for transcutaneous pacing immediately when perfusion is inadequate, and do not let an atropine attempt delay pacing.
- Attempting synchronized cardioversion during torsades de pointes: Waiting for the monitor to synchronize to the twisting, undulating QRS morphology of torsades de pointes delays critical therapy; unstable polymorphic rhythms require unsynchronized defibrillation.
- Administering AV nodal blocking agents in pre-excited atrial fibrillation: Giving adenosine, beta-blockers, diltiazem, or digoxin to a patient with Wolff-Parkinson-White and atrial fibrillation shunts electrical conduction down the accessory pathway, which can induce ventricular fibrillation.
- Assuming electrical capture equals mechanical cardiac output during pacing: Observing paced QRS complexes on the cardiac monitor without confirming a corresponding central pulse (preferably femoral) or an arterial line waveform risks missing ineffective mechanical capture.
Key points
- Symptomatic bradycardia is defined by inadequate tissue perfusion (hypotension, altered mental status, chest pain, pulmonary edema) and is managed with atropine 1 mg IV push (up to 3 mg total), transcutaneous pacing, and epinephrine or dopamine infusions titrated to hemodynamic goals.
- Mobitz Type II and wide-QRS third-degree AV block commonly suggest infranodal disease and may respond poorly to atropine; prepare for immediate transcutaneous pacing and initiate it when indicated by poor perfusion or instability, confirming both electrical and mechanical capture.
- New or presumed new left bundle branch block with ischemic symptoms requires urgent clinical evaluation for acute coronary occlusion, but LBBB alone is not an automatic STEMI equivalent or an automatic indication for reperfusion.
- Manifest ventricular pre-excitation typically produces a short PR interval, wide QRS, and delta wave, but these findings may be intermittent; in pre-excited atrial fibrillation, avoid AV nodal blockers, including adenosine, beta-blockers, diltiazem, verapamil, and digoxin, as well as intravenous amiodarone, because of the risk of ventricular fibrillation.
- Monomorphic ventricular tachycardia with a pulse is managed with synchronized cardioversion if unstable or antiarrhythmic infusions if stable, whereas pulseless VT and VF require immediate CPR, unsynchronized defibrillation, epinephrine, and amiodarone or lidocaine.
- A QTc greater than 500 milliseconds and electrolyte derangements (hypokalemia, hypomagnesemia, hypocalcemia) elevate the risk for torsades de pointes, which is treated with IV magnesium sulfate when stable or immediate unsynchronized defibrillation when unstable.
- Synchronized cardioversion delivers energy on the R wave to prevent T-wave shock delivery; care involves procedural sedation, continuous monitoring of airway, ventilation, blood pressure, and rhythm, and vigilance for amiodarone-induced hypotension and bradycardia.
Practice this section
Explained CCRN Cardiovascular questions, no account needed. CCRN Cardiovascular practice test
The full lesson continues with 4 more sections with exam tips, audio in English and Spanish, 5 Check yourself questions and 20 flashcards.
- 1 month
$58.99$29.49 - 3 months
$173.99$86.99 - Lifetime
$350.99$175.49
One payment, no subscription.
See CCRN plansAlready a member? Log in
Sample lesson: Heart Failure, Cardiogenic Shock and Post-MI Complications25 practice questions on this exam
Each CCRN practice test has 25 original questions with the answers explained. No account needed.
Open the CCRN practice testsOriginal lesson written for CCRN practice · updated October 31, 2026. Exam names are trademarks of their owners; tests.global is not affiliated with them.